PHS
TMO icon

PFM Health Sciences’s Thermo Fisher Scientific TMO Stock Holding History

PFM Health Sciences’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.29M Sell
14,832
-23,083
-61% -$12.5M 0.66% 48
2025
Q4 		$22M Buy
37,915
+35,601
+1,539% +$20.1M 2.19% 12
2025
Q3 		$1.12M Buy
+2,314
New +$1.08M 0.09% 69
2025
Q2 		– Sell
-21,897
Closed -$10.9M – 73
2025
Q1 		$10.9M Buy
21,897
+857
+4% +$464K 0.79% 33
2024
Q4 		$10.9M Sell
21,040
-37,393
-64% -$20.6M 0.68% 43
2024
Q3 		$36.1M Sell
58,433
-5,217
-8% -$3.09M 2.05% 15
2024
Q2 		$35.2M Buy
63,650
+5,612
+10% +$3.22M 1.74% 21
2024
Q1 		$33.7M Buy
58,038
+6,710
+13% +$3.77M 1.59% 23
2023
Q4 		$27.2M Sell
51,328
-10,815
-17% -$5.23M 1.63% 22
2023
Q3 		$31.5M Hold
62,143
– – 1.48% 30
2023
Q2 		$32.4M Hold
62,143
– – 1.26% 36
2023
Q1 		$35.8M Hold
62,143
– – 1.58% 30
2022
Q4 		$34.2M Hold
62,143
– – 1.23% 35
2022
Q3 		$31.5M Hold
62,143
– – 1.14% 42
2022
Q2 		$33.8M Hold
62,143
– – 1.29% 34
2022
Q1 		$36.7M Hold
62,143
– – 1.37% 33
2021
Q4 		$41.5M Sell
62,143
-9,299
-13% -$5.81M 1.41% 36
2021
Q3 		$40.8M Buy
71,442
+36,613
+105% +$20.1M 1.2% 39
2021
Q2 		$17.6M Buy
+34,829
New +$16.4M 0.55% 51
2019
Q3 		– Sell
-160,666
Closed -$47.2M – 103
2019
Q2 		$47.2M Sell
160,666
-120,770
-43% -$33.3M 0.9% 40
2019
Q1 		$77M Buy
281,436
+19,329
+7% +$4.81M 1.7% 24
2018
Q4 		$58.7M Buy
+262,107
New +$61.5M 1.56% 27
2015
Q1 		– Sell
-419,210
Closed -$52.5M – 99
2014
Q4 		$52.5M Buy
+419,210
New +$51M 1.23% 28
2014
Q3 		– Sell
-178,193
Closed -$21M – 72
2014
Q2 		$21M Sell
178,193
-458,563
-72% -$54M 0.42% 48
2014
Q1 		$76.6M Sell
636,756
-3,672
-0.6% -$437K 1.39% 25
2013
Q4 		$71.3M Sell
640,428
-1,748,818
-73% -$174M 1.43% 27
2013
Q3 		$220M Sell
2,389,246
-127,990
-5% -$11.6M 5.3% 2
2013
Q2 		$213M Buy
+2,517,236
New +$210M 4.43% 5

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PFM Health Sciences's TMO Position: Q1 2026 in Review

PFM Health Sciences reduced its Thermo Fisher Scientific (TMO) stake by 61% in Q1 2026, selling an estimated $12.5M and leaving 14,832 shares worth $7.29M. The position accounts for 0.66% of the portfolio, ranked #48.

PFM Health Sciences first reported a position in TMO in Q2 2013 and has held it in 28 quarters since. The position peaked at $220M in Q3 2013. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • PFM Health Sciences held 14,832 shares of Thermo Fisher Scientific worth $7.29M as of Q1 2026.
  • PFM Health Sciences sold 23,083 Thermo Fisher Scientific shares in Q1 2026, an estimated $12.5M.
  • Thermo Fisher Scientific made up 0.66% of PFM Health Sciences's portfolio in Q1 2026, its #48 holding.
  • PFM Health Sciences first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 28 quarters since.
  • PFM Health Sciences's Thermo Fisher Scientific position peaked at $220M in Q3 2013.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.